Company Overview
Company Name
Albany Ketamine Infusions
Address
7 Wembley Ct, Albany, NY, 12205, United States
Website
albanyketamine.comPhone
(518) 249-5700Approx. Annual Revenue
$0.9M
Employees
6
Established
2018
Google Reviews
4.6 (103 reviews)
About Albany Ketamine Infusions
Albany Ketamine Infusions is a leading provider of ketamine infusion therapy in Albany, New York. The company specializes in the treatment of depression, PTSD, anxiety, and chronic pain, offering patients relief through innovative and effective intravenous ketamine treatments.
More Companies in New York
Browse all companies in New York →
Frequently Asked Questions about Albany Ketamine Infusions
Technologies Used
;%20fill-rule:%20evenodd;%20}%20.cls-2%20{%20fill:%20none;%20}%20%3c/style%3e%3clinearGradient%20id='linear-gradient'%20x1='-1275.62'%20y1='432.1'%20x2='-1272.18'%20y2='427.35'%20gradientTransform='translate(30659%2010381.36)%20scale(24%20-24)'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20offset='0'%20stop-color='%2325c5ff'/%3e%3cstop%20offset='.45'%20stop-color='%230048ff'/%3e%3cstop%20offset='1'%20stop-color='%23c500f3'/%3e%3c/linearGradient%3e%3c/defs%3e%3cpath%20class='cls-2'%20d='M0,0H150V150H0V0Z'/%3e%3cg%20id='Layer_2'%20data-name='Layer%202'%3e%3cg%20id='Layer_1-2'%20data-name='Layer%201-2'%3e%3cg%20id='Artboard'%3e%3cg%20id='userway_logo'%20data-name='userway%20logo'%3e%3cpath%20id='Combined-Shape'%20class='cls-1'%20d='M18.75,36.94c5.16-.03,9.36,4.13,9.39,9.28,0,.03,0,.07,0,.1h0v7.3h0v23.47c0,26.79,21.71,48.5,48.5,48.5s48.5-21.71,48.5-48.5h0v-23.99h0v-7.3c-.03-5.16,4.13-9.36,9.28-9.39,.03,0,.07,0,.1,0h4.69v40.68c0,34.56-28.02,62.58-62.58,62.58S14.06,111.66,14.06,77.1h0V36.94h4.69Zm2.09-22.42c16.1-.03,29.18,13,29.2,29.1,0,.03,0,.07,0,.1v33.38c0,14.69,11.91,26.6,26.6,26.6s26.6-11.91,26.6-26.6V43.72c-.03-16.1,13-29.18,29.1-29.2,.03,0,.07,0,.1,0h6.78v14.08h-6.78c-8.35,0-15.12,6.77-15.12,15.12v33.38c0,22.18-17.98,40.16-40.16,40.16h0c-22.28,.03-40.42-17.88-40.68-40.16V43.72c-.08-8.44-6.99-15.21-15.43-15.13-.07,0-.14,0-.21,0h-6.78V14.52h6.78Z'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
'%3e%3ccircle%20id='Ellipse_1'%20data-name='Ellipse%201'%20cx='434.5'%20cy='434.5'%20r='434.5'%20transform='translate(493%2061)'%20fill='%2307223d'/%3e%3cg%20id='Group_1'%20data-name='Group%201'%20transform='translate(617.184%20224.258)'%3e%3crect%20id='Rectangle_1'%20data-name='Rectangle%201'%20width='80.606'%20height='430.93'%20transform='translate(91.97%20109.538)'%20fill='%23fdc400'/%3e%3cpath%20id='Path_1'%20data-name='Path%201'%20d='M18.4,26.659l80.606,76.473V26.659Z'%20transform='translate(73.569%20106.573)'%20fill='%2392792d'/%3e%3cpath%20id='Path_2'%20data-name='Path%202'%20d='M132.276,0,0,138.472H264.9Z'%20transform='translate(0%200)'%20fill='%23fdc400'/%3e%3crect%20id='Rectangle_2'%20data-name='Rectangle%202'%20width='92.32'%20height='236.28'%20transform='translate(263.686%20304.188)'%20fill='%232896fb'/%3e%3cpath%20id='Path_3'%20data-name='Path%203'%20d='M51.936,65.609l96.453,83.334V65.609Z'%20transform='translate(207.619%20262.276)'%20fill='%231b6198'/%3e%3cpath%20id='Path_4'%20data-name='Path%204'%20d='M36.02,177.426,168.3,38.949l132.62,138.478Z'%20transform='translate(143.992%20155.702)'%20fill='%232896fb'/%3e%3crect%20id='Rectangle_3'%20data-name='Rectangle%203'%20width='80.606'%20height='430.925'%20transform='translate(447.656%20109.608)'%20fill='%234acf27'/%3e%3cpath%20id='Path_5'%20data-name='Path%205'%20d='M89.575,26.672l80.606,76.473V26.672Z'%20transform='translate(358.083%20106.625)'%20fill='%23327f3e'/%3e%3cpath%20id='Path_6'%20data-name='Path%206'%20d='M71.172,138.49h264.9L203.448.012Z'%20transform='translate(284.514%200.051)'%20fill='%234acf27'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Key Decision Makers
Philip Hansen Owner
Glen Brooks Owner